Increasing Dedication of Roche's R&D for Cancer mAbs
The market for monoclonal antibody is generally influenced by increasing size of potential cancer market therby prompted pharmaceutical players to invest in oncology sector. Such monoclonal antibodies are driving the cancer therapy market and have become a vital treatment option for a varied number of cancer types. Multiple applications for the same monoclonal antibody for different cancer types have also increased in the recent past. Several cancer monoclonal antibodies are in market and a lot more in pipeline specific to...
View full press release